A Phase II International Multi-center Open label Proof of concept study of BN83495 in Postmenapausal Women with Advanced Metastatic or Recurrent Oestrogen Receptor (ER) Positive Endometrial carcinoma who have received one line of Chemotherapy in the Adju
|Effective start/end date||9/1/10 → 9/30/13|
- Ipsen Innovation
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.